09.01.2020
- Japanese drugmaker Astellas Pharma has boosted its immuno-oncology capabilities with the purchase of US-based Xyphos Biosciences. The acquisition was the second last month for the...
10.12.2019
- Japanese drugmaker Astellas Pharma has announced plans to acquire US gene therapy company Audentes Therapeutics for around $3 billion. The boards of directors of both companies...
28.06.2017
- The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its...
07.04.2017
- Japan’s Astellas Pharma has agreed to buy privately held Belgian drug developer Ogeda in a transaction worth up to €800 million. The acquisition expands the Tokyo-headquartered...
29.06.2016
- The US federal government’s National Institutes of Health (NIH) has declined a petition from a public interest group to lower the price of a drug for advanced prostate cancer...
21.11.2013
- The U.S. Food and Drug Administration warned physicians on Wednesday that two chemicals used to conduct cardiovascular stress tests can cause heart attacks and death, and it...
18.07.2013
- Chinese authorities investigating the alleged bribery of doctors and officials by GlaxoSmithKline have stopped the drugmaker's head of finance for China, a British citizen, from...
19.04.2013
- Japan's Astellas Pharma and Britain's GlaxoSmithKline are competing to develop a new kind of medicine that boosts production of red blood cells by making the body think it is at...
